Jump to main content
Jump to site search

Issue 7, 2019
Previous Article Next Article

AIEgen functionalized inorganic–organic hybrid nanomaterials for cancer diagnosis and therapy

Author affiliations

Abstract

Theranostics, possessing both imaging and therapeutic functions, has emerged as a promising strategy for the efficient treatment of cancer. Aggregation-induced emission luminogen (AIEgen) functionalized inorganic–organic hybrid nanomaterials have attracted great interest in biomedicine due to their distinct advantages, such as good biocompatibility, excellent fluorescence properties, facile functionalization, etc., which can be used as good platforms for the integration of cancer diagnosis and therapeutics. This review presents AIEgen functionalized inorganic–organic hybrid nanomaterials with multifunctions for imaging and therapy, including fluorescence single modal imaging, fluorescence-magnetic resonance dual modal imaging, fluorescence-computed tomography dual modal imaging, fluorescence imaging-guided chemotherapy, fluorescence imaging-guided photothermal therapy, and fluorescence imaging-guided chemo-photothermal synergistic therapy. Finally, we also provide the recent trends and our personal perspectives on the advantages of AIEgen-functionalized inorganic–organic hybrid nanomaterials in theranostics, and systematically summarize their future challenges in cancer theranostics.

Graphical abstract: AIEgen functionalized inorganic–organic hybrid nanomaterials for cancer diagnosis and therapy

Back to tab navigation

Publication details

The article was received on 13 Apr 2019, accepted on 23 May 2019 and first published on 24 May 2019


Article type: Review Article
DOI: 10.1039/C9QI00411D
Inorg. Chem. Front., 2019,6, 1613-1622

  •   Request permissions

    AIEgen functionalized inorganic–organic hybrid nanomaterials for cancer diagnosis and therapy

    D. Li, Inorg. Chem. Front., 2019, 6, 1613
    DOI: 10.1039/C9QI00411D

Search articles by author

Spotlight

Advertisements